Opposition Tempers Cuts To Japan’s High-Cost Healthcare Benefits

Japan's MHLW has decided to tone down planned policy revisions that would have cut benefits under a patient support scheme for high-priced drugs, after resistance from patient groups.

Japan's high-cost healthcare benefit
Japan's attempt to shrink its high-cost healthcare benefit faced larger-than-expected opposition (Shutterstock)

More from Japan

More from Market Access